Continuous cardiac telemetry stands at the forefront of modern healthcare, offering uninterrupted monitoring of a patient's heart activity. This dynamic process involves the use of cutting-edge technology to remotely observe and analyze a patient's heart rhythm and vital signs in real-time. The intricate system employs specialized devices equipped with wireless capabilities, transmitting data seamlessly from sensors attached to the patient's body to a central monitoring station. Tailored for individuals with known or suspected heart conditions, continuous cardiac telemetry plays a pivotal role in early anomaly detection, enabling swift intervention when needed. The wealth of data obtained through this method empowers healthcare providers to gain comprehensive insights into a patient's cardiac health, facilitating informed decisions about personalized treatment plans and timely interventions. This proactive and precise approach to cardiac monitoring is paramount in elevating patient care standards and optimizing outcomes for those managing cardiovascular concerns.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation